GSK’s Witty loses bonus over China scandal
February 28, 2014Medical Communications, Sales and Marketing China, GSK, Witty, sales, sir andrew
GlaxoSmithKline’s chief executive Sir Andrew Witty received bonuses “lower than they otherwise might have been” last year due to the …
Packer Forbes Communications adds managing director
February 28, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Packer Forbes, joella webber
Comms agency Packer Forbes Communications is strengthening its leadership team by appointing Joella Webber as managing director. Webber who was …
NICE rejects Alimta
February 28, 2014Sales and Marketing Alimta, Cancer, NHS, NICE, NSCLC, lilly, pemetrexed
Eli Lilly is coming to terms with rejection by NICE after the cost watchdog said it would not recommend Alimta …
Novartis extends trial transparency
February 27, 2014Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Goldacre, Novartis, alltrials, transparency
Novartis has become the latest pharmaceutical company to allow greater scrutiny of its clinical trial data.
MPs concerned about care.data
February 27, 2014Medical Communications, Sales and Marketing Dorrell, HSCIC, MPs, NHS, UK, care data, care.data, data
MPs have expressed concerns about security in the delayed NHS care.data programme which will see medical information routinely swapped between …
Novartis to axe Horsham site
February 27, 2014Manufacturing and Production, Research and Development, Sales and Marketing Horsham, Novartis, closure, cuts, research, restructure
Novartis has confirmed that it will cease all of its pharmaceutical operations at its Horsham, West Sussex site this year. …
Biotech industry failed by UK, says UCB
February 27, 2014Research and Development, Sales and Marketing Cimzia, NHS, UCB, biotech, doliveux, tellier, vimpat
The UK biotechnology industry has ‘missed the boat’ and not fulfilled its potential, according to outgoing UCB chief executive Roch …
Best of Health Awards judges appointed
February 27, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Best of Health, IPA, henderson
The 2014 IPA Best of Health Awards which highlight the top creative advertising agencies in the industry has named the …
Mid Staffs to be ‘dissolved’
February 27, 2014Sales and Marketing Hunt, Mid Staffs, NHS, NHS England, tsas
The scandal-hit Mid Staffordshire NHS Foundation Trust is to be dissolved, after health secretary Jeremy Hunt accepted the recommendation of …
InterMune scores in lung trial
February 26, 2014Research and Development, Sales and Marketing Esbriet, FDA, IPF, InterMune, fvc, lung
InterMune has taken another step on its lengthy road to get the US regulator to approve its drug Esbriet for …
BMS/AZ fat disorder drug gains FDA approval
February 26, 2014Research and Development, Sales and Marketing AstraZeneca, BMS, FDA, hep C, metreleptin, myalept
Bristol-Myers Squibb and partner AstraZeneca have been granted FDA approval for a new drug to treat rare and potentially fatal …
Bupa hires MHP Health head
February 26, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BUPA, gowrley, mhp health
Rupert Gowrley is leaving his role as joint head at MHP Health in order to start with Bupa as its …
Lilly’s diabetes drug matches Victoza
February 26, 2014Research and Development, Sales and Marketing EMA, FDA, Victoza, dulaglutide, lilly
Eli Lilly’s once-weekly diabetes candidate dulaglutide has matched Novo Nordisk’s established once-daily Victoza (liraglutide) when it comes to lowering blood …
FDA: India needs more inspectors
February 25, 2014Manufacturing and Production FDA, India, generics, hamburg
The Food and Drug Administration is to put more inspectors on the ground in India, following a visit there by …
Samsung focussing increasingly on health tech
February 25, 2014Medical Communications, Sales and Marketing Apple, Samsung, digital, health tech, innovation lab, smartwatch
Samsung has partnered with a US university to create a digital health innovation laboratory whilst also unveiling some new health-tracking …
UCB names next chief executive
February 25, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UCB, tellier
Biopharma firm UCB has confirmed its current chief executive Roch Doliveux is to be replaced by Jean-Christophe Tellier. Tellier (pictured) …
NICE restricts Yervoy use
February 25, 2014Sales and Marketing BMS, Cancer, NHS, NICE, Yervoy, melanoma
Bristol-Myers Squibb has been dealt a blow by NICE after the UK cost watchdog recommended that the use of skin …
FDA given $20 million for generic testing
February 24, 2014Manufacturing and Production, Sales and Marketing ADHD, FDA, generics, hamburg
The FDA has been given $20 million to help it assess generic treatments, a group of drugs that makes up …
Europe poised for generic Symbicort
February 24, 2014Manufacturing and Production, Sales and Marketing AstraZeneca, CHMP, COPD, Symbicort, Teva, breo, generics
The CHMP has given Teva Pharmaceutical Industries a lift by recommending that its generic version of AstraZeneca’s lung drug Symbicort …
CHMP breathes new life into GSK, Teva and Novartis
February 24, 2014Research and Development, Sales and Marketing CHMP, COPD, EMA, GSK, Gilead, Teva, asthma, onoro
The CHMP has given its backing to a number of new treatments for respiratory diseases, which include two from London-based …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
